Font Size: a A A
Keyword [activator inhibitor-1]
Result: 101 - 120 | Page: 6 of 10
101. Effects Of Angiotension Ⅱ On Fibrinolytic System Through AT1 Receptor And ERK Pathway In Rats With Acute Myocardial Infarction
102. The Relationship Between The Plasma Levels Of Plasminogen Activator Inhibitor-1 And The Type 2 Diabetes Mellitus Macro-vascular Complication In The Patients With Different Age
103. Effects Of Polysaccharide Of Laminaria L01 On The Expression And Secretion Of T-PA And PAI-1 In Cultured Human Umbilical Vein Endothelial Cell
104. Study Of Correlation Between Plasma Von Willebrand Factor And Plasminogen Activator Inhibitor-1 Levels With Short-term Prognosis Of Acute Coronary Syndromes.
105. The Effect Of Amiloride-an Inhibitor Of Urokinase On The Pathology Of Rat COPD Model
106. Study Of The Postprandial Lipids Metabolism After Oral Fatty Test And Its Assiociation With The Endothelial Function In Elderly Diabetic Patients
107. Effects Of Shear Stress On Expression Of Tissue Plasminogen Activator (tPA) And Plasminogen Activator Inhibitor-1 (PAI-1) Of Rat Kidney Proximal Tubular Epithelial Cells Cultured In High Glucose And Its Significance
108. The Expression Of MVD, HIF-1α, TGF-β3 And PAI-1 In Placenta Of Severe Pre-eclampsia
109. The Role Of The Plasminogen Activator Inhibitor-1 In The Pathogenesis Of Hepatic Fibrosis
110. The Study On The Effect Of Tissue-type Plasminogen Activator And Its Inhibitor-1 On The Formation Of Pulmonary Thromboembolism
111. Significance And Effect Of Curcumin On The Expression Of Composition Of The Plasminogen Activating System In Hepatic Fibrosis
112. The Mechanisms And Effects Of Hirudo In Bleomycin-induced Pulmonary Fibrosis Of Rats
113. Low Molecular Weight Heparin On Coagulation And Fibrinolysis System Of Patients With Acute Coronary Syndrome: Clinical Study Of Its Effects, Avalability
114. Study On Rosiglitazone In Prevention Of Renal Lesion In Streptozotocin-induced Diabetic Rats
115. Regulation Of Insulin-induced PAI-1 Secretion By Silencing Caveolin-1 In Human Vascular Endothelial Cells
116. Association Of Plasminogen Activator Inhibitor-1 4G/5G Polymorphism And Type 2 Diabetes With Early Nephropathy
117. The Study On The Correleation Between Urokinase-type Plasminogen Activator And Plasminogen Activator Inhibitor-1 And The Invasion And Metastasis Of Ovarion Epithelial Cancer
118. Effects Of Insulin Intensive Therapy On The Level Of C-reactive Protein And PAI-1 Of The Patients With Acute Myocardial Infarction
119. Plasma Concentrations' Changes And Significance Of Plasminogen Activator, Plasminogen Activator Receptor And Plasminogen Activator Inhibitor-1 In Chronic Glomerulonephritis And The Intervenient Research On Them
120. Clinical Observation Of Ligustrazin On Treatment Of Cerebrovasospasm After Spontaneous Subarachnoid Hemorrhage
  <<First  <Prev  Next>  Last>>  Jump to